LU82738A1 - Derives d'aminothiols,leur preparation et utilisation ainsi que compositions contenant ces derives - Google Patents

Derives d'aminothiols,leur preparation et utilisation ainsi que compositions contenant ces derives Download PDF

Info

Publication number
LU82738A1
LU82738A1 LU82738A LU82738A LU82738A1 LU 82738 A1 LU82738 A1 LU 82738A1 LU 82738 A LU82738 A LU 82738A LU 82738 A LU82738 A LU 82738A LU 82738 A1 LU82738 A1 LU 82738A1
Authority
LU
Luxembourg
Prior art keywords
formula
linear
methyl
radical
branched
Prior art date
Application number
LU82738A
Other languages
English (en)
French (fr)
Inventor
Claude Gillet
Joseph Roba
Michel Snyers
Georges Lambelin
Paul Niebes
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Priority to LU82738A priority Critical patent/LU82738A1/fr
Priority to SE8104958A priority patent/SE8104958L/xx
Priority to DE19813133293 priority patent/DE3133293A1/de
Priority to IT23611/81A priority patent/IT1137642B/it
Priority to ZA815912A priority patent/ZA815912B/xx
Priority to AU74654/81A priority patent/AU7465481A/en
Priority to FI812640A priority patent/FI812640L/fi
Priority to IL63664A priority patent/IL63664A0/xx
Priority to NL8103993A priority patent/NL8103993A/nl
Priority to JP56134793A priority patent/JPS5798255A/ja
Priority to BE0/205790A priority patent/BE890116A/fr
Priority to GR65879A priority patent/GR74348B/el
Priority to GB8126304A priority patent/GB2083036A/en
Priority to PT73593A priority patent/PT73593B/pt
Priority to ES505037A priority patent/ES8307735A1/es
Priority to NO812944A priority patent/NO812944L/no
Priority to FR8116512A priority patent/FR2489325A1/fr
Priority to DK382281A priority patent/DK382281A/da
Publication of LU82738A1 publication Critical patent/LU82738A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU82738A 1980-08-29 1980-08-29 Derives d'aminothiols,leur preparation et utilisation ainsi que compositions contenant ces derives LU82738A1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
LU82738A LU82738A1 (fr) 1980-08-29 1980-08-29 Derives d'aminothiols,leur preparation et utilisation ainsi que compositions contenant ces derives
SE8104958A SE8104958L (sv) 1980-08-29 1981-08-21 Aminotiolderivat, framstellning och anvendning derav, samt kompositioner innehallande sadana derivat
DE19813133293 DE3133293A1 (de) 1980-08-29 1981-08-22 Derivate von aminothiolen, verfahren zu deren herstellung, deren anwendung und solche derivate enthaltende pharmazeutische zubereitungen
IT23611/81A IT1137642B (it) 1980-08-29 1981-08-24 Derivati di amminotioli,loro preparazione e loro impiego e anche composizioni contenenti questi derivati
ZA815912A ZA815912B (en) 1980-08-29 1981-08-26 Derivatives of aminothiols
AU74654/81A AU7465481A (en) 1980-08-29 1981-08-26 Aminothiols
FI812640A FI812640L (fi) 1980-08-29 1981-08-26 Aminotiolderivat deras framstaellning och anvaendning samt dessa derivat innehaollande kompositioner
IL63664A IL63664A0 (en) 1980-08-29 1981-08-26 Derivatives of aminothiols
NL8103993A NL8103993A (nl) 1980-08-29 1981-08-27 Aminothiolderivaten, bereiding en toepassing ervan alsmede preparaten, die deze derivaten bevatten.
JP56134793A JPS5798255A (en) 1980-08-29 1981-08-27 Aminot hiol derivative, manufacture, usage and drug containing same
BE0/205790A BE890116A (fr) 1980-08-29 1981-08-27 Derives d'aminothiols, leur preparation et utilisation ainsi que compositions contenant ces derives
GR65879A GR74348B (es) 1980-08-29 1981-08-27
GB8126304A GB2083036A (en) 1980-08-29 1981-08-28 Aminothiol derivatives, their preparation and use, and compositions containing them
PT73593A PT73593B (fr) 1980-08-29 1981-08-28 Procede de preparation de derives d'aminothiols leur utilisation ainsi que compositions contenant ces derives
ES505037A ES8307735A1 (es) 1980-08-29 1981-08-28 Procedimiento para la preparacion de derivados de aminotio- les
NO812944A NO812944L (no) 1980-08-29 1981-08-28 Fremgangsmaate ved fremstilling av nye aminotiolderivater
FR8116512A FR2489325A1 (fr) 1980-08-29 1981-08-28 Derives d'aminothiols, leur preparation et utilisation ainsi que compositions contenant ces derives
DK382281A DK382281A (da) 1980-08-29 1981-08-28 Fremgangsmaade til fremstilling af aminotiolderivater

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU82738A LU82738A1 (fr) 1980-08-29 1980-08-29 Derives d'aminothiols,leur preparation et utilisation ainsi que compositions contenant ces derives
LU82738 1980-08-29

Publications (1)

Publication Number Publication Date
LU82738A1 true LU82738A1 (fr) 1982-05-10

Family

ID=19729472

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82738A LU82738A1 (fr) 1980-08-29 1980-08-29 Derives d'aminothiols,leur preparation et utilisation ainsi que compositions contenant ces derives

Country Status (18)

Country Link
JP (1) JPS5798255A (es)
AU (1) AU7465481A (es)
BE (1) BE890116A (es)
DE (1) DE3133293A1 (es)
DK (1) DK382281A (es)
ES (1) ES8307735A1 (es)
FI (1) FI812640L (es)
FR (1) FR2489325A1 (es)
GB (1) GB2083036A (es)
GR (1) GR74348B (es)
IL (1) IL63664A0 (es)
IT (1) IT1137642B (es)
LU (1) LU82738A1 (es)
NL (1) NL8103993A (es)
NO (1) NO812944L (es)
PT (1) PT73593B (es)
SE (1) SE8104958L (es)
ZA (1) ZA815912B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
US4638051A (en) * 1984-04-30 1987-01-20 The Johns Hopkins University Brain imaging radiopharmaceuticals

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2505870A (en) * 1947-05-09 1950-05-02 Phillips Petroleum Co Secondary and tertiary alkylthiol amines and their production
US3337625A (en) * 1961-09-18 1967-08-22 Lilly Co Eli Amino-acetylenic compounds
US3312732A (en) * 1962-02-28 1967-04-04 Monsanto Res Corp Aminoalkyl aminoalkanethiols
US3356730A (en) * 1964-11-25 1967-12-05 Monsanto Res Corp Mercaptoalkyl oxyalkyl amines
GB1138738A (en) * 1966-12-01 1969-01-01 Eastman Kodak Co Aziridine derivatives
US3622676A (en) * 1968-11-20 1971-11-23 Constance Anthony D Alonzo Smoking suppression
CA992105A (en) * 1970-03-26 1976-06-29 Exxon Research And Engineering Company Polythioethers formed by anionic ring opening of episulfides
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
CH632906A5 (en) * 1976-08-09 1982-11-15 Givaudan & Cie Sa Use of bifunctional N,S-compounds as flavourings

Also Published As

Publication number Publication date
BE890116A (fr) 1982-03-01
DK382281A (da) 1982-03-01
IL63664A0 (en) 1981-11-30
FR2489325A1 (fr) 1982-03-05
DE3133293A1 (de) 1982-04-08
AU7465481A (en) 1982-03-04
IT1137642B (it) 1986-09-10
JPS5798255A (en) 1982-06-18
ES505037A0 (es) 1983-08-16
PT73593B (fr) 1982-11-10
FI812640L (fi) 1982-03-01
NL8103993A (nl) 1982-03-16
ZA815912B (en) 1982-08-25
ES8307735A1 (es) 1983-08-16
NO812944L (no) 1982-03-01
IT8123611A0 (it) 1981-08-24
GB2083036A (en) 1982-03-17
PT73593A (fr) 1981-09-01
SE8104958L (sv) 1982-03-01
GR74348B (es) 1984-06-26

Similar Documents

Publication Publication Date Title
EP0521787B1 (fr) Nouveaux complexes de vanadium, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0005689B1 (fr) Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
CA1132543A (fr) Procede de preparation de nouveaux derives du 3-(aminoethyl) phenol et de leurs sels
EP0007824B1 (fr) Nouveaux dérivés de benzofuranne, leur procédé de préparation et composition thérapeutiqueles contenant.
EP0010460B1 (fr) Nouveaux dérivés de pyrrolidine-2-méthanol, procédé pour leur préparation et médicaments les contenant
EP0213984A1 (fr) Nouveaux dérivés de l'indole carboxamide, leurs sels, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant
FR2617402A1 (fr) Derives du thiophene et leur procede de fabrication et medicaments les contenant
EP0237366B1 (fr) Aminoalcools, leur procédé de préparation et leurs applications, notamment en thérapeutique
FR2625678A1 (fr) Agents anorexigenes a base de n-(quinuclidin-3-yl)-benzamides ou thiobenzamides
CA2030732C (fr) Nouveaux derives du thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant
EP0364350B1 (fr) Dérivés de méthyl-4[(phényl-4 pipérazinyl-1)-2 éthyl]-5 thiazole, leur procédé de préparation et les compositions pharmaceutiques en contenant
EP0395528B1 (fr) Dérivés du 4-phénylméthyl 1H-indole, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant.
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
FR2521140A1 (fr) Derives d'imidazolidine, leur preparation et leur application en therapeutique
EP0376850A1 (fr) Dérivés du benzène, leur préparation et compositions pharmaceutiques les contenant
LU82738A1 (fr) Derives d'aminothiols,leur preparation et utilisation ainsi que compositions contenant ces derives
FR2608598A1 (fr) Nouveaux derives de l'indane, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
EP0280603A1 (fr) Enantiomères de configuration absolue S de dérivés amide de l'amino-3 quinuclidine, leur procédé de préparation et leur application en thérapeutique
CA1253153A (fr) Derives d'(arylpiperazinylethylaminoethoxy)-4 phenol, leur methode de preparation et leur application therapeutique
EP0061406B1 (fr) Dérivés d'acide benzamido-alkyl-hydroxamique, procédé de préparation et composition thérapeutique
EP0275762B1 (fr) Dérivés de l'indole carboxamide ainsi que leurs sels, procédé et intermédiaires de préparation, application à titre de médicaments de ces dérivés et compositions les renfermant
EP0322296B1 (fr) Dérivés oxyimino du thiazole, procédé de préparation et utilisation en thérapeutique
FR2507180A1 (fr) Nouvelles phenylalkylamines, leur preparation et leur application comme medicaments
CA1057292A (fr) 2-amino thiazoles
EP0288647B1 (fr) Dérivés du [(pyrrolidinyl-1)-2éthoxy]-5 p-cymène, le procédé de préparation desdits dérivés et les médicaments contenant lesdits dérivés